Vitamin e and Intal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vitamin e (tocopherols and tocotrienols) and Intal (cromolyn sodium). Common drug interactions include coma among females.

The phase IV clinical study analyzes what interactions people have when they take Vitamin e and Intal. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Vitamin e?

Vitamin e has active ingredients of tocopherols and tocotrienols. It is often used in vitamin supplementation. eHealthMe is studying from 42,279 Vitamin e users. Check the latest studies of Vitamin e.

What is Intal?

Intal has active ingredients of cromolyn sodium. It is often used in asthma. eHealthMe is studying from 1,621 Intal users. Check the latest studies of Intal.

On Jul, 18, 2026

13 people who take Vitamin e and Intal together, and have interactions are studied.

What are the common drug interactions of Vitamin E and Intal, by gender? *:

female:

Coma (state of unconsciousness lasting more than six hours)
Dizziness
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Abdominal distension
Anaemia (lack of blood)
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
Blood glucose increased
Cardiac flutter (abnormal heart rhythm)
Colitis pseudomembranous (antibiotic-associated diarrhoea)
Dehydration (dryness resulting from the removal of water)

male:

n/a

What are the common drug interactions of Vitamin E and Intal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
Colitis pseudomembranous (antibiotic-associated diarrhoea)
Fatigue (feeling of tiredness)
Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Vomiting

20-29:

Cystic fibrosis (disease of the secretary glands)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Vestibular disorder (disorders of the body's balance (vestibular) system in the inner ear)

30-39:

n/a

40-49:

Blood glucose increased
Cardiac flutter (abnormal heart rhythm)
Dizziness
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Feeling hot
Heart rate increased
Injection site urticaria (rash of round, red welts on the skin at injection site)
Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

Coma (state of unconsciousness lasting more than six hours)
Hallucination (an experience involving the perception of something not present)
Influenza
Methicillin-resistant staphylococcal aureus infection
Pneumonia
Feeling drunk
Gait abnormal
Anaemia (lack of blood)
Dehydration (dryness resulting from the removal of water)
Diffuse alveolar damage (common manifestation of drug-induced lung injury)

60+:

Abdominal distension
Dizziness
Polycythaemia (proportion of blood volume that is occupied by red blood cells increases)
Pruritus (severe itching of the skin)
Dyspnoea exertional (breathlessness or shortness of breath)
Epistaxis (bleed from the nose)
Haemangioma of liver (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in liver)
Hepatic cyst
Hepatomegaly (abnormal enlargement of the liver)
Hypervolaemia (abnormally increased volume of blood)

What are the existing conditions these people have? *

Post-Traumatic Stress Disorder: 2 people, 15.38%
Menopause (end of monthly cycles in women): 2 people, 15.38%
Insomnia (sleeplessness): 2 people, 15.38%
Hepatitis C: 2 people, 15.38%
Depression: 2 people, 15.38%
Back Pain: 2 people, 15.38%
Osteoporosis (bones weak and more likely to break): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Vitamin e and Intal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously